Azacitidine treatment in AML cell lines was also shown to cause several pro-apoptotic changes, including a decrease in MCL1 protein levels[163,164] and an increase in NOXA through activation of the integrated stress response[157]. This evidence concerns the gene PMAIP1 and acute myeloid leukemia.